Unmet Needs in Appendiceal Neuroendocrine Neoplasms.


Journal

Neuroendocrinology
ISSN: 1423-0194
Titre abrégé: Neuroendocrinology
Pays: Switzerland
ID NLM: 0035665

Informations de publication

Date de publication:
2019
Historique:
received: 16 07 2018
accepted: 18 09 2018
pubmed: 21 9 2018
medline: 18 12 2019
entrez: 21 9 2018
Statut: ppublish

Résumé

Appendiceal neuroendocrine neoplasms (ANEN) are mostly discovered coincidentally during appendicectomy and usually have a benign clinical course; thus, appendicectomy alone is considered curative. However, in some cases, a malignant potential is suspected, and therefore additional operations such as completion right hemicolectomy are considered. The existing European Neuroendocrine Tumour Society (ENETS) guidelines provide useful data about epidemiology and prognosis, as well as practical recommendations with regards to the risk factors for a more aggressive disease course and the indications for a secondary operation. However, these guidelines are based on heterogeneous and retrospective studies. Therefore, the evidence does not seem to be robust, and there are still unmet needs in terms of accurate epidemiology and overall prognosis, optimal diagnostic and follow-up strategy, as well as identified risk factors that would indicate a more aggressive surgical approach at the beginning and a more intense follow-up. In this review, we are adopting a critical approach of the ENETS guidelines and published series for ANEN, focusing on the above-noted "grey areas".

Identifiants

pubmed: 30235454
pii: 000493894
doi: 10.1159/000493894
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

37-44

Investigateurs

Detlef Bartsch (D)
Rudolf Arnold (R)
Eric Baudin (E)
Lisa Bodei (L)
Ivan Borbath (I)
Jaume Capdevila (J)
Martyn Caplin (M)
Jie Chen (J)
Frederico Costa (F)
Anne Couvelard (A)
Jaroslaw Ćwikła (J)
Philippa Davies (P)
Herder de (H)
Massimo Falconi (M)
Jenny Falkerby (J)
Nicola Fazio (N)
Diego Ferone (D)
Andrea Frilling (A)
Rocio Garcia-Carbonero (R)
Simona Glasberg (S)
Vera Gorbunova (V)
Ashley Grossman (A)
Dieter Hörsch (D)
Robert Jensen (R)
Gregory Kaltsas (G)
Günter Klöppel (G)
Ulrich Knigge (U)
Beata Kos-Kudła (B)
Guenter Krejs (G)
Eric Krenning (E)
Matthew Kulke (M)
Steven Lamberts (S)
van Nieveen (V)
Juan O'Connor (J)
Dermot O'Toole (D)
Ulrich-Frank Pape (UF)
Stefano Partelli (S)
Marianne Pavel (M)
Marc Peeters (M)
John Ramage (J)
Nicholas Reed (N)
Guido Rindi (G)
Anja Rinke (A)
Philippe Ruszniewski (P)
Halfdan Sorbye (H)
Anders Sundin (A)
Jean-Yves Scoazec (JY)
Babs Taal (B)
Janson Tiensuu (J)
Christos Toumpanakis (C)
Juan Valle (J)
Marie-Pierre Vullierme (MP)
Staffan Welin (S)
Bertram Wiedenmann (B)

Informations de copyright

© 2018 S. Karger AG, Basel.

Auteurs

Christos Toumpanakis (C)

Neuroendocrine Tumour Unit, Royal Free Hospital, London, United Kingdomc.toumpanakis@ucl.ac.uk.

Nicola Fazio (N)

Division of Gastrointestinal Medical Oncology and Neuroendocrine Tumors, European Institute of Oncology, IEO, Milan, Italy.

Eva Tiensuu Janson (E)

Endocrine Oncology Unit, Department of Medical Sciences, Uppsala University, Uppsala, Sweden.

Dieter Hörsch (D)

Center for Neuroendocrine Tumors Bad Berka, Bad Berka, Germany.

Andreas Pascher (A)

Department of Surgery, Campus Charité Mitte/Campus Virchow-Klinikum, Charité University Medicine Berlin, Berlin, Germany.

Nicholas Reed (N)

Beatson Oncology Centre, Gartnavel General Hospital, Glasgow, United Kingdom.

Dermot O Apos Toole (D)

Department of Clinical Medicine, St. James's Hospital, Trinity College Dublin, Dublin, Ireland.

Els Nieveen van Dijkum (E)

Department of Surgery, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Stefano Partelli (S)

Pancreatic Surgery Unit, Pancreas Translational and Clinical Research Center, San Raffaele Scientific Institute, "Vita-Salute" University, Milan, Italy.

Anja Rinke (A)

Department of Gastroenterology, UKGM, Marburg, Marburg, Germany.

Beata Kos-Kudla (B)

Department of Endocrinology and Neuroendocrine Tumors, Department of Pathophysiology and Endocrinology, Medical University of Silesia, Katowice, Poland.

Frederico Costa (F)

Hospital Sírio-Libanês, São Paulo, Brazil.

Ulrich-Frank Pape (UF)

Division of Hepatology and Gastroenterology, Medical Department, Charité Campus Charité Mitte/Campus Virchow-Klinikum, Charité University Medicine Berlin, Berlin, Germany.

Simona Grozinsky-Glasberg (S)

Neuroendocrine Tumor Unit, Department of Endocrinology, Hadassah-Hebrew University Medical Centre, Jerusalem, Israel.

Jean-Yves Scoazec (JY)

Department of Pathology, Gustave Roussy Cancer Campus, Villejuif, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH